Inventor · disambiguated record
Nello Mainolfi
Also filed as: MAINOLFI NELLO
40 granted patents·20 pending applications·401 citations·filing 2009–2025
98Inventor score
Files withKYMERA THERAPEUTICS INC35RAZE THERAPEUTICS INC10ARTMAN III GERALD DAVID6ADAMS CHRISTOPHER MICHAEL4NOVARTIS AG2
Top patents by PatentIndex Score
60 records- 0198US11746120B2Stat degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Sep 5, 2023·12 cites·30 claims
- 0298US11723980B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Aug 15, 2023·9 cites·14 claims
- 0398US11485750B1STAT degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted Nov 1, 2022·7 cites·20 claims
- 0498US11117889B1IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted Sep 14, 2021·28 cites·28 claims
- 0598US10874743B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2018·Granted Dec 29, 2020·38 cites·20 claims
- 0697US12258341B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Granted Mar 25, 2025·5 cites·18 claims
- 0797US12168057B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Granted Dec 17, 2024·5 cites·17 claims
- 0897US12077555B2STAT degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Sep 3, 2024·3 cites·14 claims
- 0997US11807636B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Nov 7, 2023·6 cites·19 claims
- 1096US12006329B2Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Jun 11, 2024·4 cites·9 claims
- 1196US11512080B2CRBN ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Nov 29, 2022·15 cites·20 claims
- 1296US11358948B2CRBN ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2018·Granted Jun 14, 2022·16 cites·16 claims
- 1396US11352350B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Jun 7, 2022·20 cites·11 claims
- 1496US9056874B2Complement pathway modulators and uses thereofADAMS CHRISTOPHER MICHAEL·Filed 2013·Granted Jun 16, 2015·95 cites·29 claims
- 1596US8501756B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Aug 6, 2013·65 cites·3 claims
- 1695US12091411B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Granted Sep 17, 2024·5 cites·9 claims
- 1795US11318205B1IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2020·Granted May 3, 2022·10 cites·14 claims
- 1894US12150995B2IRAK degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2021·Granted Nov 26, 2024·4 cites·15 claims
- 1992US11932635B2CRBN ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Granted Mar 19, 2024·1 cites·21 claims
- 2090US11623932B2Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2018·Granted Apr 11, 2023·3 cites·13 claims
- 2189US11485743B2Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2019·Granted Nov 1, 2022·6 cites·8 claims
- 2289US9682968B2Piperidinyl-indole derivatives complement factor B inhibitors and uses thereofADAMS CHRISTOPHER MICHAEL·Filed 2014·Granted Jun 20, 2017·15 cites·17 claims
- 2387US11014882B23-phosphoglycerate dehydrogenase inhibitors and uses thereofRAZE THERAPEUTICS INC·Filed 2017·Granted May 25, 2021·3 cites·12 claims
- 2487US2025000985A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2586US11535593B23-phosphoglycerate dehydrogenase inhibitors and uses thereofRAZE THERAPEUTICS INC·Filed 2021·Granted Dec 27, 2022·1 cites·18 claims
- 2686US10954220B23-phosphoglycerate dehydrogenase inhibitors and uses thereofRAZE THERAPEUTICS INC·Filed 2017·Granted Mar 23, 2021·3 cites·16 claims
- 2785US10093663B2Piperidinyl-indole derivatives complement factor B inhibitors and uses thereofNOVARTIS AG·Filed 2017·Granted Oct 9, 2018·5 cites·18 claims
- 2885US2025059221A1Stat degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2981US9676728B22-benzyl-benzimidazole complement factor B inhibitors and uses thereofADAMS CHRISTOPHER·Filed 2014·Granted Jun 13, 2017·6 cites·12 claims
- 3081US2025051320A1Crbn ligands and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3180US9475806B2Complement factor B inhibitors and uses there ofADAMS CHRISTOPHER MICHAEL·Filed 2014·Granted Oct 25, 2016·6 cites·14 claims
- 3280US8242125B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2009·Granted Aug 14, 2012·3 cites·19 claims
- 3379US11370792B2Caffeine inhibitors of MTHFD2 and uses thereofRAZE THERAPEUTICS INC·Filed 2016·Granted Jun 28, 2022·2 cites·20 claims
- 3476US2025011325A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3576US2023312536A13-phosphoglycerate dehydrogenase inhibitors and uses thereofRAZE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3675US12264132B23-phosphoglycerate dehydrogenase inhibitors and uses thereofRAZE THERAPEUTICS INC·Filed 2022·Granted Apr 1, 2025·0 cites·16 claims
- 3775US2025214977A1Stat6 inhibitors and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3875US2025121073A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3975US2025325673A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4074US2025163042A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4173US2023115184A1Protein degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4271US2023303526A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4371US2024059674A1Irak degraders and uses thereofKYMERA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4468US11634412B23-phosphoglycerate dehydrogenase inhibitors and uses thereofRAZE THERAPEUTICS INC·Filed 2021·Granted Apr 25, 2023·0 cites·19 claims
- 4564US12187728B2Caffeine inhibitors of MTHFD2 and uses thereofRAZE THERAPEUTICS INC·Filed 2022·Granted Jan 7, 2025·0 cites·16 claims
- 4664US2023061841A1Shmt inhibitors and uses thereofRAZE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4763US11091451B2SHMT inhibitors and uses thereofRAZE THERAPEUTICS INC·Filed 2017·Granted Aug 17, 2021·0 cites·11 claims
- 4862US8541432B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Sep 24, 2013·0 cites·3 claims
- 4962US8492393B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Jul 23, 2013·0 cites·6 claims
- 5062US8486954B2Heterobicyclic carboxamides as inhibitors for kinasesARTMAN III GERALD DAVID·Filed 2012·Granted Jul 16, 2013·0 cites·3 claims
Showing the top 50 of 60 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Nello Mainolfi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →